Investing.com
Earnings call: Regeneron reports steady growth, prepares for new launches By Investing.com
Regeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ: REGN) reported a solid start to 2024, with first-quarter revenues showing a 7% increase year-over-year, excluding...with Sanofi (NASDAQ ...
1 hour ago